(1S,2R,3S,5R)-3-phenylmethoxy-2-(phenylmethoxymethyl)-6-oxabicyclo[3.1.0]hexane

We are (1S,2R,3S,5R)-3-phenylmethoxy-2-(phenylmethoxymethyl)-6-oxabicyclo[3.1.0]hexane CAS:110567-22-1 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

Chemical Name:(1S,2R,3S,5R)-3-phenylmethoxy-2-(phenylmethoxymethyl)-6-oxabicyclo[3.1.0]hexane
CAS.NO:110567-22-1
Synonyms:(1S,2R,3S,5R)-3-phenylmethoxy-2-(phenylmethoxymethyl)-6-oxabicyclo[3.1.0]hexane
(1S,2R,3S,5R)-3-(Benzyloxy)-2-((benzyloxy)methyl)-6-oxabicyclo[3,1,0]hexane
(1S,2R,3S,5R)-3-(Phenylmethoxy)-2-[(phenylmethoxy)methyl]-6-oxabicyclo[3.1.0]hexane
(2R,3S)-benzyloxy-2-benzyloxymethyl-6-oxabicyclo<3.1.0>hexane
(1S,2R,3S,5R)-3-(benzyloxy)-2-(benzyloxymethyl)-6-oxabicyclo[3.1.0]hexane
 
Physical and Chemical Properties:
Density 1.2±0.1 g/cm3
Boiling Point 427.9±40.0 °C at 760 mmHg
Molecular Formula C20H22O3
Molecular Weight 310.387
Flash Point 145.9±24.6 °C
 
Specification:
Appearance:Yellow Liquid
Assay(HPLC):≥95.0%
Moisture:≤0.1%
Total impurities:≤5.0%
 
Packing:25 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:Intermediate of Entecavir(CAS:142217-69-4).

(1S,2R,3S,5R)-3-phenylmethoxy-2-(phenylmethoxymethyl)-6-oxabicyclo[3.1.0]hexane


Related News: From the perspective of the corresponding formulation manufacturer, the drug substance needs to meet the requirements of impurities and stability. The production base must pass the international quality system certifications such as cGMP and EuGMP. At the same time, the drug substance company must have sufficient capacity.5-Fluoro-2-methylaniline If the drug is in a syrup form, then the excipient is the liquid that has been used to make it as such.7- (5-oxo-3 – ((trietilsilil) oxi) ciclopento-1-en-1-il) heptanoato de (R) -metilo CAS:118456-54-5 Myelodysplastic syndromes (MDS) are conditions that can occur when the blood-forming cells in the bone marrow become dysfunctional and thus produce an inadequate number of circulating blood cells.1,4-Diaminobenzene Dihydrochloride Myelodysplastic syndromes (MDS) are conditions that can occur when the blood-forming cells in the bone marrow become dysfunctional and thus produce an inadequate number of circulating blood cells.In an August overhaul to its drug administration law, Beijing said conditional approval could be granted to some still-under-research medicines of “predictable” clinical value for life-threatening diseases for which effective treatment is not immediately available.

Related Products
Product Name
Diethoxyphosphorylmethyl 4-methylbenzenesulfonate View Details
4-Bromo-3-methylbenzoic acid View Details
2-Bromo-4-cyanopyridine View Details
N-acetylglycine manufacturer (R)-1-(naphthalen-1-yl)ethanamine manufacturer Argireline manufacturer 1-Bromo-6-chlorohexane manufacturer Phenylacetic acid manufacturer